AstraZeneca Teams Up with BrightInsight

March 26, 2020

BrightInsight, Inc. (San Jose, CA), provider of a regulated Internet of Things (IoT) platform for biopharma and medtech, has announced global digital health partnership with AstraZeneca. AZ will develop apps, algorithms, Software as a Medical Device and connected devices on top of the BrightInsight Platform “that enhance and personalize care while making overall healthcare delivery more efficient for patients and providers.” The first major program the companies are collaborating on is in the chronic disease management space.   “We quickly dismissed the concept of building our own custom platform so we could focus instead on developing transformational digital health solutions...” commented Karan Arora, Chief Commercial Digital Officer and Global Vice President, AstraZeneca. “We selected BrightInsight because its pre-built, compliant platform accelerates our time to market while allowing us to focus on digital health innovation and leveraging our clinical know-how to improve patient outcomes instead of the underlying infrastructure.”  

BrightInsight, Inc. (San Jose, CA), provider of a regulated Internet of Things (IoT) platform for biopharma and medtech, has announced global digital health partnership with AstraZeneca. AZ will develop apps, algorithms, Software as a Medical Device and connected devices on top of the BrightInsight Platform “that enhance and personalize care while making overall healthcare delivery more efficient for patients and providers.” The first major program the companies are collaborating on is in the chronic disease management space.   “We quickly dismissed the concept of building our own custom platform so we could focus instead on developing transformational digital health solutions...” commented Karan Arora, Chief Commercial Digital Officer and Global Vice President, AstraZeneca. “We selected BrightInsight because its pre-built, compliant platform accelerates our time to market while allowing us to focus on digital health innovation and leveraging our clinical know-how to improve patient outcomes instead of the underlying infrastructure.”